Hikma Pharmaceutical reported $1.21B in Sales Revenues for its first fiscal semester of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Sales Change
Artemis Alpha ATS:LN GBP -25863000 16.53M
AstraZeneca AZN:LN USD 10.98B 211M
Bayer BAYN:GR EUR 11.28B 1.54B
Fresenius FRE:GR EUR 10.46B 441M
Fresenius Medical Care FMS:US EUR 5.1B 339.49M
Galapagos GLPG:NA EUR 148.04M 473K
Genmab GEN:DC DKK 4.09B 925M
GlaxoSmithKline GSK:LN GBP 7.83B 685.07B
Hikma Pharmaceutical HIK:LN USD 1.21B 124M
Merck MRK:GR EUR 5.81B 238M
Orion ORNBV:FH EUR 491.8M 208.1M
Recordati REC:IM EUR 485.05M 11.94M
Roche Holding ROG:VX CHF 32.3B 207M